Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H10N2O4 |
Molecular Weight | 258.2295 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1N(C2CCC(=O)NC2=O)C(=O)C3=CC=CC=C13
InChI
InChIKey=UEJJHQNACJXSKW-UHFFFAOYSA-N
InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
Molecular Formula | C13H10N2O4 |
Molecular Weight | 258.2295 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:11:52 UTC 2023
by
admin
on
Fri Dec 15 16:11:52 UTC 2023
|
Record UNII |
4Z8R6ORS6L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
43890
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
80194
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
30788
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
WHO-ATC |
L04AX02
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
115598
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
43790
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
NDF-RT |
N0000008663
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
WHO-VATC |
QL04AX02
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
90795
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/01/067
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
NDF-RT |
N0000008663
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
585417
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
110197
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
72092
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
NCI_THESAURUS |
C129820
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
114998
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
NCI_THESAURUS |
C1742
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
121898
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
187204
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
94995
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
NCI_THESAURUS |
C574
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
32188
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
THALIDOMIDE CELGENE (AUTHORIZED: MUTIPLE MYELOMA)
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
NCI_THESAURUS |
C54677
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
82594
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
||
|
LIVERTOX |
NBK548371
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
50-35-1
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
527179
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
10432
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | RxNorm | ||
|
4Z8R6ORS6L
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
DTXSID9022524
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
100000089194
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
1652500
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
4Z8R6ORS6L
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
74947
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
D013792
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
5426
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
66847
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
DB01041
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
7327
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
CHEMBL468
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
THALIDOMIDE
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
SUB10958MIG
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
9513
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
C870
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
200-031-1
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
762
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
2616
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | |||
|
m10673
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY | Merck Index | ||
|
3586
Created by
admin on Fri Dec 15 16:11:52 UTC 2023 , Edited by admin on Fri Dec 15 16:11:52 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Kd
|
||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
TARGET -> INHIBITOR |
BINDING
|
||
|
TARGET -> INHIBITOR |
Dose-dependent interaction with the CRBN-DDB1 complex
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
CYP2C9 and CYP1A2 were also mediators in this reaction.
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |